About: http://hub.abes.fr/oup/periodical/annonc/2005/volume_16/issue_1/w

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : http://hub.abes.fr/oup/periodical/annonc/2005/volume_16/issue_1/w Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Issue
Is Part Of	http://hub.abes.fr/oup/periodical/annonc/2005/volume_16
has manifestation of work	http://hub.abes.fr/oup/periodical/annonc/2005/volume_16/issue_1/m/print http://hub.abes.fr/oup/periodical/annonc/2005/volume_16/issue_1/m/web
Date Copyrighted	2005
Rights	© 2005 European Society for Medical Oncology
issue	1
is Is Part Of of	Macronutrients, fatty acids, cholesterol and prostate cancer risk Workgroup III: facilitating screening for colorectal cancer: quality assurance and evaluation. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002) A Foundation for the future Phase II study of E7070 in patients with metastatic melanoma The Global Challenge of Colorectal Cancer. Reports from the UICC International Workshop on Facilitating Screening for Colorectal Cancer: An International Agenda Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience Renal cell carcinoma: review of novel single-agent therapeutics and combination regimens Phase I/II trial of gene therapy with autologous tumor cells modified with tag7/PGRP-S gene in patients with disseminated solid tumors Phase II randomized trial of vinorelbine and gemcitabine versus carboplatin and paclitaxel in advanced non-small-cell lung cancer Cancer genetic counselling Impact of EGFR expression on colorectal cancer patient prognosis and survival A randomized phase III trial of adjuvant chemotherapy with UFT for completely resected pathological stage I non-small-cell lung cancer: the West Japan Study Group for Lung Cancer Surgery (WJSG)—the 4th study Workgroup I: criteria for screening. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002) Phase II randomised trial comparing docetaxel given every 3 weeks with weekly schedule as second-line therapy in patients with advanced non-small-cell lung cancer (NSCLC) Inhibitory effect of recombinant adenovirus carrying melittin gene on hepatocellular carcinoma Third generation aromatase inhibitors may prevent endometrial growth and reverse tamoxifen-induced uterine changes in postmenopausal breast cancer patients Touch imprint cytologic preparations and the diagnosis of head and neck mass lesions Workgroup II: the screening process. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002) Teenage kicks Neoplastic Diseases of the Blood Prognostic factors in ovarian cancer: how close are we to a complete picture? Principles of Molecular Oncology Phase I/II study of capecitabine and vinorelbine in pretreated patients with metastatic breast cancer Retroperitoneal lymph node dissection versus chemotherapy for stage I testicular nonseminomas Cologne high-dose sequential chemotherapy in relapsed and refractory Hodgkin lymphoma: results of a large multicenter study of the German Hodgkin Lymphoma Study Group (GHSG) Does the nadir CA125 concentration predict a long-term outcome after chemotherapy for carcinoma of the ovary? Proteomic analysis for the early detection and rational treatment of cancer—realistic hope? Clinical implications of expression of cyclooxygenase-2 related to angiogenesis in uterine endometrial cancers Statement by members of the Ponte di Legno group on the right of children with leukemia to have full access to essential treatment for acute lymphoblastic leukemia Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience Extended rituximab therapy in Waldenström's macroglobulinemia A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly) Workgroup V: professional education and advocacy. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002) Sequential two-line strategy for stage IV non-small-cell lung cancer: docetaxel-cisplatin versus vinorelbine-cisplatin followed by cross-over to single-agent docetaxel or vinorelbine at progression: final results of a randomised phase II study Reply to “Early subcutaneous wash-out in acute extravasations”, by R. Giunta (Ann Oncol 2004; 15: 1146), and to the reply by D. Schrijvers (Ann Oncol 2004; 15: 1147) In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study Workgroup IV: public education. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002) Recommendations for a Global Core Curriculum in Medical Oncology Ann Oncol 2004; 15: 1603-1612

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata